PF-07321332 (Paxlovid) for R&D purpose only 99.0% Powder Echemi
GMP ISO
2628280-40-8
Pharmaceutical Grade
99%
Shanghai
Echemi
as per customers' requirements
2022-05-31
API,Intermediate
-
Product Description
-
Seller Information
-
DescriptionECHEMI Editorial ReferencePF-07321332 is an azabicyclohexane that is (1R,5S)-3-azabicyclo[3.1.0]hexane substituted by {(1S)-1-cyano-2-[(3S)-2-oxopyrrolidin-3-yl]ethyl}aminoacyl, 3-methyl-N-(trifluoroacetyl)-L-valinamide, methyl and methyl groups at positions 2S, 3, 6 and 6, respectively. It is an inhibitor of SARS-CoV-2 main protease which is currently under clinical development for the treatment of COVID-19. It has a role as an EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor and an anticoronaviral agent. It is a nitrile, a member of pyrrolidin-2-ones, a secondary carboxamide, a pyrrolidinecarboxamide, a tertiary carboxamide, an organofluorine compound and an azabicyclohexane.
PF-07321332 is an oral COVID-19 antiviral clinical candidate. By inhibiting the main protease, PF-07321332 prevents the virus from cleaving long protein chains into the parts it needs to reproduce itself.
Paxlovid is a new potential drug discovered by Pfizer. Paxlovid is composed of two active ingredients, Nirmatrelvir and Ritonavir. Similarly, a mixture of Lopinavir and Ritonavir drugs is already used against HIV. Ritonavir is a drug approved in 1996 which is widely used, not exclusively, to treat HIV/AIDS. Another component of Paxlovid, Nirmatrelvir (PF-07321332) is a new potential drug developed by Pfizer. It inhibits the SARS-CoV-1 virus protease (Mpro), which fragments long protein chains into the parts the virus needs to reproduce. Nirmatrelvir acts as a substrate for the virus protease in the cell, thereby deceiving the virus and blocking its replication.CertificatesBasic Info-
Product Name:
Paxlovid
Other Name:PF-07321332;3-Azabicyclo[3.1.0]hexane-2-carboxamide,N- [(1S)-1-cyano-2-[(3S)-2-oxo-3-pyrrolidinyl]ethyl]- 3-[(2S)-3,3-dimethyl-1-oxo-2-[(2,2,2- trifluoroacetyl)amino]butyl]-6,6-dimethyl-, (1R,2S,5S)-;PF07321332(Paxlovid);nirmatrelvir;Nirmatrelvir (PF-07321332);PF-07321332-005;(1R,2S,5S)-N-[(1S)-1-cyano-2-[(3S)-2-oxopyrrolidin-3-yl]ethyl]-3-[(2S)-3,3-dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butanoyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide;3-Azabicyclo[3.1.0]hexane-2-carboxamide,N- [(1S)-1-cyano-2-[...
CAS No.:2628280-40-8
Molecular Formula:C23H32F3N5O4
InChIKeys:LIENCHBZNNMNKG-OJFNHCPVSA-N
Molecular Weight:499.53
Exact Mass:499.24063901
EC Number:605-001-5
UNII:7R9A5P7H32
Color/Form:White to off-white
Categories:
Characteristics-
Density:
1.267±0.06 g/cm3(Predicted)
Boiling Point:742.4±60.0 °C(Predicted)
PKA:10.26±0.46(Predicted)
Critical Temperature & Pressure:Store at -20°C
-
-
Seller Information
-
Business Type:
Distributor
-
Main Products:
API,Intermediate
-
Payment Terms:
TT against copy of documents,L/C
-
Average lead Time:
30 days
-
Total Annual Revenue:
Above $100 million
-
Total Employees:
201-300
About Echemi Pharmaceutical
Echemi’s philosophy is to seek for higher quality, to explore frontier area. The progress of human society, the extension of life expectancy, and the conquest of disease are all derived from the numerous businesses and individuals who have quietly dedicated themselves in the pharmaceutical industry. It’s the controlling of supply chain quality that ensures the efficacy. It’s the continuous exploration that promotes the development of the pharmaceutical industry and benefits more future generations. The pursuit of high quality requires all partners of Echemi Pharmaceutical to be screened, whether its certificate, qualification or scale. In the field of renewal, we will embrace all new changes and make more contributions to the development of pharmaceutical industry.
Advantage for Pharmaceutical
• Having been working in pharmaceutical field for more then 15 years, we have experienced regulatory team, quality control team, sourcing team, technical support team, and logistics team. And we are familiar with the regulatory requirements from different areas, can offer tailored service for our customers.
• We have hundreds of strategic partners for APIs, intermediates, and custom synthesis. All of our partners are ready to support our customers with documents, and be audited.
• We can offer custom synthesis for some new chemical structures and some materials which there are no reliable suppliers.
Product Category
We care for human and animal health and we are committed to creating a better social environment.
• Human API
• Intermediate
• Veterinary API
• Agrochemical
• Fine Chemical
• Custom Synthesis
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product
More from this Seller
-
-
![Atorvastatin Calcium API]( "Atorvastatin Calcium API")
-
Atorvastatin Calcium API
Pharmaceutical Grade / 99%
-
-
-
![Polyvinyl Alcohol(PVA)-ECHEMI]( "Polyvinyl Alcohol(PVA)-ECHEMI")
-
Polyvinyl Alcohol(PVA)-ECHEMI
Pharmaceutical Grade
-
-
-
![Imatinib base]( "Imatinib base")
-
Imatinib base
Pharmaceutical Grade / 99%
-
-
-
![Enlicitide Decanoate]( "Enlicitide Decanoate")
-
Enlicitide Decanoate
Pharmaceutical Grade
-
-
-
![Sodium Starch Glycolate-SSG]( "Sodium Starch Glycolate-SSG")
-
Sodium Starch Glycolate-SSG
Pharmaceutical Grade
-
-
-
![(S)-benzyl 2-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)pyrrolidine-1-carboxylate]( "(S)-benzyl 2-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)pyrrolidine-1-carboxylate")
-
(S)-benzyl 2-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)pyrrolidine-1-carboxylate
Pharmaceutical Grade / 99%
-
![(S)-benzyl 2-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)pyrrolidine-1-carboxylate](https://file.echemi.com/fileManage/upload/goodpicture/20200522/m20200522155610260.jpg "(S)-benzyl 2-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)pyrrolidine-1-carboxylate")